- Home
- BFRG vs EVAX Comparison
BFRG vs EVAX Comparison
Compare BFRG & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRG
- EVAX
- Stock Information
- Founded
- BFRG 2017
- EVAX 2008
- Country
- BFRG United States
- EVAX Denmark
- Employees
- BFRG N/A
- EVAX N/A
- Industry
- BFRG Retail: Computer Software & Peripheral Equipment
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BFRG Technology
- EVAX Health Care
- Exchange
- BFRG Nasdaq
- EVAX Nasdaq
- Market Cap
- BFRG 16.4M
- EVAX 17.8M
- IPO Year
- BFRG 2023
- EVAX 2021
- Fundamental
- Price
- BFRG $1.36
- EVAX $2.94
- Analyst Decision
- BFRG
- EVAX Strong Buy
- Analyst Count
- BFRG 0
- EVAX 2
- Target Price
- BFRG N/A
- EVAX $10.00
- AVG Volume (30 Days)
- BFRG 98.0K
- EVAX 71.6K
- Earning Date
- BFRG 11-07-2025
- EVAX 10-30-2025
- Dividend Yield
- BFRG N/A
- EVAX N/A
- EPS Growth
- BFRG N/A
- EVAX N/A
- EPS
- BFRG N/A
- EVAX N/A
- Revenue
- BFRG $33,257.00
- EVAX $3,176,000.00
- Revenue This Year
- BFRG N/A
- EVAX N/A
- Revenue Next Year
- BFRG N/A
- EVAX $425.50
- P/E Ratio
- BFRG N/A
- EVAX N/A
- Revenue Growth
- BFRG N/A
- EVAX 1042.45
- 52 Week Low
- BFRG $1.09
- EVAX $1.20
- 52 Week High
- BFRG $4.84
- EVAX $17.20
- Technical
- Relative Strength Index (RSI)
- BFRG 54.55
- EVAX 52.53
- Support Level
- BFRG $1.30
- EVAX $2.81
- Resistance Level
- BFRG $1.27
- EVAX $3.04
- Average True Range (ATR)
- BFRG 0.08
- EVAX 0.19
- MACD
- BFRG 0.02
- EVAX -0.01
- Stochastic Oscillator
- BFRG 79.26
- EVAX 71.19
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.